Patents by Inventor PHILIPPE DELATAILLE

PHILIPPE DELATAILLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT OF LIVER FAILURE
    Publication number: 20240000754
    Abstract: The invention relates to the treatment or prevention of liver failure.
    Type: Application
    Filed: November 16, 2021
    Publication date: January 4, 2024
    Inventors: Philippe DELATAILLE, Robert WALCZAK, Corinne FOUCART, Vanessa LEGRY, Nicolas STANKOVIC VALENTIN, Simon DEBAECKER, Rémy HANF
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20220323422
    Abstract: The present invention relates to a synergistic combination of active ingredients for use in the treatment of fibrotic diseases.
    Type: Application
    Filed: June 28, 2022
    Publication date: October 13, 2022
    Inventors: Robert WALCZAK, Corinne FOUCART, Philippe DELATAILLE
  • Methods of treatment for cholestatic and fibrotic diseases
    Patent number: 11400078
    Abstract: The present invention relates to a synergistic combination of active ingredients for use in the treatment of fibrotic diseases.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: August 2, 2022
    Assignee: GENFIT
    Inventors: Robert Walczak, Corinne Foucart, Philippe Delataille
  • Methods of treatment for cholestatic and fibrotic diseases
    Patent number: 11103484
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: August 31, 2021
    Assignee: Genfit
    Inventors: Raphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
  • Methods of treatment for cholestatic and fibrotic diseases
    Patent number: 10905680
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: February 2, 2021
    Assignee: GENFIT
    Inventors: Raphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20200338047
    Abstract: The present invention relates to a synergistic combination of active ingredients for use in the treatment of fibrotic diseases.
    Type: Application
    Filed: May 13, 2020
    Publication date: October 29, 2020
    Inventors: Robert WALCZAK, Corinne FOUCART, Philippe DELATAILLE
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20200316031
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Application
    Filed: June 24, 2020
    Publication date: October 8, 2020
    Inventors: Raphael DARTEIL, Robert WALCZAK, Carole BELANGER, Emilie NEGRO, Pierre DAUBERSIES, Philippe DELATAILLE
  • Methods of treatment for cholestatic and fibrotic diseases
    Patent number: 10653678
    Abstract: The present invention relates to synergistic combination of active ingredients for use in the treatment of fibrotic diseases.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: May 19, 2020
    Assignee: GENFIT
    Inventors: Robert Walczak, Corinne Foucart, Philippe Delataille
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20190083468
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Application
    Filed: December 4, 2018
    Publication date: March 21, 2019
    Inventors: Raphael DARTEIL, Robert WALCZAK, Carole BELANGER, Emilie NEGRO, Pierre DAUBERSIES, Philippe DELATAILLE
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20190000813
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Application
    Filed: September 19, 2018
    Publication date: January 3, 2019
    Inventors: Raphael DARTEIL, Robert WALCZAK, Carole BELANGER, Emilie NEGRO, Pierre DAUBERSIES, Philippe DELATAILLE
  • Methods of treatment for cholestatic and fibrotic diseases
    Patent number: 10130613
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: November 20, 2018
    Assignee: Genfit
    Inventors: Raphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
  • Methods of treatment for cholestatic and fibrotic diseases
    Patent number: 10130612
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: November 20, 2018
    Assignee: Genfit
    Inventors: Raphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
  • Methods of treatment for cholestatic and fibrotic diseases
    Patent number: 10117855
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: November 6, 2018
    Assignee: Genfit
    Inventors: Raphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
  • Methods of treatment for cholestatic and fibrotic diseases
    Patent number: 10117856
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: November 6, 2018
    Assignee: Genfit
    Inventors: Raphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20180280358
    Abstract: The present invention relates to synergistic combination of active ingredients for use in the treatment of fibrotic diseases.
    Type: Application
    Filed: April 20, 2018
    Publication date: October 4, 2018
    Inventors: Robert WALCZAK, Corinne FOUCART, Philippe DELATAILLE
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20180092885
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Application
    Filed: December 14, 2017
    Publication date: April 5, 2018
    Inventors: Raphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20180092886
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Application
    Filed: December 14, 2017
    Publication date: April 5, 2018
    Inventors: Raphael DARTEIL, Robert WALCZAK, Carole BELANGER, Emilie NEGRO, Pierre DAUBERSIES, Philippe DELATAILLE
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20180092884
    Abstract: The present invention relates to the compound [2-[(5-nitro-1, 3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Application
    Filed: December 14, 2017
    Publication date: April 5, 2018
    Inventors: Raphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
  • METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES
    Publication number: 20180085354
    Abstract: The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
    Type: Application
    Filed: December 11, 2017
    Publication date: March 29, 2018
    Inventors: Raphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
  • METHODS OF TREATMENT OF CHOLESTASIS AND FIBROSIS
    Publication number: 20170290814
    Abstract: The present invention relates compounds useful and their use for treating cholestatic and fibrotic diseases.
    Type: Application
    Filed: March 13, 2017
    Publication date: October 12, 2017
    Inventors: MATHIEU DUBERNET, ROBERT WALCZAK, PHILIPPE DELATAILLE